NR-49064甲型流感病毒,A/布里斯班/59/2007(H1N1)(适应水貂细胞)(病毒）

NR-49064??Influenza A virus, A/Brisbane/59/2007 (H1N1) (Mink Cell Adapted)(Viruses)|Influenza A virus|A/Brisbane/59/2007 (H1N1) (Mink Cell Adapted)|-60°C or colder|BEI ResourcesAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Influenza A Virus, A/Brisbane/59/2007 (H1N1) (Mink Cell Adapted), NR-49064."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.NR-49064 was derived through adaptation of BEI Resources NR-31657 to growth in Neovison vison lung epithelial cells (Mv 1 Lu; ATCC ^? CCL-64?). NR-31657 was in turn derived through adaptation of BEI Resources NR-12282 to growth in Madin-Darby canine kidney cells (MDCK; ATCC ^? CCL-34?). Influenza A virus, A/Brisbane/59/2007 (H1N1) was originally isolated from a 47-year-old female in Brisbane, Queensland, Australia on July 1, 2007, and was passaged in embryonated chicken eggs at the isolating laboratory, the Center for Disease Control and Prevention, and the Baylor College of Medicine prior to deposit to BEI Resources.Sequence information is available for influenza A virus, A/Brisbane/59/2007 (H1N1) at the Influenza Research Database. The World Health Organization recommended influenza A/Brisbane/59/2007 (H1N1)-like viruses for use as vaccines during the 2008-2009 and 2009-2010 Northern Hemisphere influenza seasons and during the 2009 Southern Hemisphere influenza season.Note: Mink lung epithelial cells have been shown to support the replication of influenza A and B viruses to high titer. Virus yields of many low passage influenza A strains are higher in Mv 1 Lu than in MDCK cells.Each vial contains approximately 1 mL of cell lysate and supernatant from Neovison vison lung epithelial cells (Mv 1 Lu; ATCC ^? CCL-64?) infected with mink cell adapted influenza A virus, A/Brisbane/59/2007 (H1N1).